Investing In Caredx Inc (NASDAQ: CDNA): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

The company is listed on the NASDAQ and operates within the Diagnostics & Research industry segment. The current market capitalization of Caredx Inc is $892.00M. A total of 1.53 million shares were traded on the day, compared to an average of 919.73K shares.

In the most recent transaction, COURNOYER CHRISTINE sold 29,136 shares of CDNA for 15.96 per share on May 12 ’25. After the transaction, the Director now owns 37,045 company shares. In a previous transaction on May 12 ’25, COURNOYER CHRISTINE bought 29,136 shares at 15.96 per share.

Among the insiders who bought shares, Christine M. Cournoyer acquired of 12,000 shares on May 12 ’25 at a per-share price of $15.36. In another insider transaction, COURNOYER CHRISTINE sold 16,700 shares at $14.13 per share on May 06 ’25. Company shares held by the Director now total 37,045.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CDNA has a high of $34.84 and a low of $12.90.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $6.84, while its Total Shareholder’s Equity was $465.88M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 4.25.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.